Intercalation of drugs in layered double hydroxides and their controlled release: A review
Source abstract
Abstract
Abstract The intercalation of different drugs in layered double hydroxides with the hydrotalcite-like structure is reviewed. The intercalation processes are carried out following different routes (direct synthesis, coprecipitation, anion exchange) and the advantages and disadvantages of these methods are described for the specific drug/LDH system studied. Characterisation of the intercalation compounds is also studied, to determine the way the guest molecules are intercalated between the layers of the layered double hydroxide. The controlled release (in some cases also the kinetics analysis) is also studied. We conclude that layered double hydroxides are very suitable materials to host different families of drugs and in the controlled release they show benefitial properties, on comparing with the effect of the bulk drug. It should be also stressed that these are almost the unique materials (in addition to layered hydroxy salts) able to host drugs in the anionic form, so nicely completing the studies carried out so far on the suitability of cationic clays to host cationic or neutral drugs.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Layered Double Hydroxides Synthesis and Applications · Inorganic Chemistry and Materials · Magnesium Oxide Properties and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Delamination of layered double hydroxides by use of surfactants10.1039/a908251d ↗
2. Direct intercalation of amino acids into layered double hydroxides by coprecipitation10.1006/jssc.2001.9340 ↗
3. Intercalation behavior of l-ascorbic acid into layered double hydroxides10.1016/j.clay.2006.09.003 ↗
4. Catalytic properties of hydrotalcite-type anionic clays
5. Effect of gliclazide immobilization into layered double hydroxide on drug release10.1016/j.ejpb.2009.06.007 ↗
6. Stability of vitamin C derivatives in solution and topical formulations10.1016/S0731-7085(96)01904-8 ↗
7. Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia10.1016/j.atherosclerosis.2006.11.035 ↗
8. Applications of hydrotalcite-type anionic clays (layered double hydroxides) in catalysis
9. New layered double hydroxides/phospholipid bilayer hybrid material with strong potential for sustained drug delivery system10.1021/cm803426j ↗
10. Microwave-treated layered double hydroxides containing Ni2+ and Al3+: the effect of added Zn10.1016/j.jssc.2006.08.010 ↗
11. Uniform fast growth of hydrotalcite-like compounds10.1021/cg0506222 ↗
12. Influence of microwave radiation on the textural properties of layered double hydroxides10.1016/j.micromeso.2006.03.038 ↗
13. Microwave-assisted reconstruction of Ni–Al hydrotalcite-like compounds10.1016/j.jssc.2008.02.003 ↗
14. Microwave-assisted homogeneous precipitation of hydrotalcites by urea hydrolysis10.1021/ic7023023 ↗
15. Microwaves and layered double hydroxides: a smooth understanding10.1351/PAC-CON-08-07-01 ↗
16. Nanocomposite formulation system of lipid-regulating drugs based on layered double hydroxide: synthesis, characterization and drug release properties10.1007/s11095-010-0175-x ↗
17. Novel method to evaluate diffusion controlled release of drug from resinate10.1016/0378-5173(86)90147-X ↗
18. Comparison of the epoxidation of cyclohexene, dicyclopentadiene and 1,5-cyclooctadiene over LDH hosted Fe and Mn sulfonato–salen complexes10.1016/j.molcata.2005.12.042 ↗
19. Synthesis, characterization, and ion exchange properties of hydrotalcite Mg6Al2(OH)16(A)x(A−)2−x·4H2O (A, A′=Cl−, Br−, I−, and NO3−, 2≥x≥0) derivatives10.1021/cm034231r ↗
20. Impact of levetiracetam on mood and cognition during prednisone therapy10.1016/j.eurpsy.2007.06.002 ↗
21. Layered hydroxide salts: synthesis, properties and potential applications10.1016/j.ssi.2007.04.016 ↗
22. Structural and texture evolution with temperature of layered double hydroxides intercalated with paramolybdate anions10.1021/ic0508674 ↗
23. Thermal evolution of a MgAl hydrotalcite-like material intercalated with hexaniobate10.1002/ejic.200600580 ↗
24. Hydrotalcite-type anionic clays: preparation, properties and applications10.1016/0920-5861(91)80068-K ↗
25. Role of chromium in human health and in diabetes10.2337/diacare.27.11.2741 ↗
26. Catalysis by layered materials: a review10.1016/j.micromeso.2007.03.011 ↗
27. Vitiligo, psoralen, and melanogenesis: some observations and understanding10.1111/j.1600-0749.1996.tb00098.x ↗
28. Effect of process variatons on anticancerous drug intercalation in ceramic based delivery system10.1080/0371750X.2010.11090840 ↗
29. Layered double hydroxides based ceramic nanocapsules as reservoir and carrier of functional anions10.1080/0371750X.2010.11090832 ↗
30. Layered double hydroxide: inorganic organic conjugate nanocarrier for methotrexate10.1016/j.jpcs.2011.03.012 ↗
31. Methotrexate intercalated Zn, Al-layered double hydroxide10.1016/j.jssc.2011.07.015 ↗
32. A facile synthetic strategy for Mg–Al layered double hydroxide material as nanocarrier for methotrexate10.1016/j.ceramint.2011.08.014 ↗
33. Structural characteristics and thermal properties of PE-g-MA/Mg, Al-LDH exfoliation nanocomposites synthetized by solution intercalation10.1021/cm030044h ↗
34. Intercalation of organic and inorganic anions into layered double hydroxides10.1039/c39890000926 ↗
35. Anticancer drug-layered hydroxide nanohybrids as potent cancer chemotherapy agents10.1016/j.jpcs.2007.10.140 ↗
36. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance10.1039/b925831k ↗
37. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study10.1166/jnn.2010.1415 ↗
38. Intercalation of vitamer into LDH and their controlled release properties10.5012/bkcs.2004.25.1.122 ↗
39. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide10.1021/ja981823f ↗
40. Inorganic layered double hydroxide as nonviral vectors10.1002/1521-3773(20001117)39:22<4041::AID-ANIE4041>3.0.CO;2-C ↗
41. Cellular uptake behavior of [gamma-P-32] labeled ATP–LDH nanohybrids10.1039/b008680k ↗
42. Layered double hydroxide as an efficient drug reservoir for folate derivatives10.1016/j.biomaterials.2003.09.083 ↗
43. Clay minerals and layered double hydroxides for novel biological applications10.1016/j.clay.2006.07.007 ↗
44. Basic properties of Mg2+1−xAl3+x layered double hydroxides intercalated by carbonate, hydroxide, chloride and sulphate anions10.1021/ic00108a020 ↗
45. Layered double hydroxides and their intercalation compounds in photochemistry and in medicinal chemistry
46. Intercalation and grafting of hydrogen phosphates and phosphonates into synthetic hydrotalcites and a.c.-conductivity of the compounds there by obtained10.1016/S0167-2738(97)00043-X ↗
47. New synthetic routes to hydrotalcite-like compounds—characterisation and properties of the obtained materials10.1002/(SICI)1099-0682(199810)1998:10<1439::AID-EJIC1439>3.0.CO;2-1 ↗
48. Recent progress in the synthesis and application of organically modified hydrotalcites10.1524/zkri.2009.1153 ↗
49. Modified hydrotalcite-like compounds as active fillers of biodegradable polymers for drug release and food packaging applications10.2174/187221012803531493 ↗
50. LDH in physical, chemical, biochemical and life sciences
51. Hidróxidos duplos lamelares: Nanpartículas inorgánicas para armazenamento e liberaçao de espécies de interesse biologico e terapêutico (in Portuguese)10.1590/S0100-40422010000100029 ↗
52. Bio-nanocomposites based on layered double hydroxides10.1021/cm0483240 ↗
53. Layered double hydroxides: synthesis and post-synthesis modification
54. Surface and textural properties of hydrotalcite-like materials and their decomposition products10.1016/S0167-2991(08)63112-2 ↗
55. Intercalation of [Cr(C2O4)3]3− complex in Mg, Al layered double hydroxide10.1021/ic034034u ↗
56. An FT-IR study of the adsorption and reactivity of ethanol on systems derived from Mg2Al-W7O246− layered double hydroxides10.1039/B309070A ↗
57. Synthesis and characterization of new Mg2Al-paratungstate layered double hydroxides10.1021/ic0347790 ↗
58. Mg, Al layered double hydroxides with intercalated indomethacin: synthesis, characterization and pharmacological study10.1002/jps.20054 ↗
59. Release studies of different NSAIDs encapsulated in Mg, Al, Fe-hydrotalcites10.1016/j.clay.2008.06.014 ↗
60. Self-assembly and characterization of layered double hydroxide/DNA hybrids10.1021/nl052020a ↗
61. Crystal structure and X-ray identification of layered double hydroxides
62. 2006 · 119 · 1
63. Structural aspects of layered double hydroxides
64. Base catalysis in the synthesis of fine chemicals10.1023/B:TOCA.0000029802.75155.5a ↗
65. Modelling of l-DOPA enzymatic oxidation catalyzed by l-amino acid oxidase from Crotalus adamanteus and Rhodococcus opacus10.1016/j.bej.2005.08.022 ↗
66. Environmental remediation involving layered double hydroxides
67. Layered double hydroxides (LDH)
68. Foye · 1995
69. Thermogravimetric analysis of layered double hydroxides with chloramphenicol and salicylate in the interlayer space10.1007/s10973-007-8381-4 ↗
70. Amino acid-pillared layered double hydroxide and montmorillonite —thermal characteristics10.1023/A:1010190315865 ↗
71. Preparation and characterization of hybrid organic–inorganic composite materials using the amphoteric property of amino acids: amino acid intercalated layered double hydroxide and montmorillonite10.1021/ic981176t ↗
72. On the stability of ascorbic acid in emulsified systems for topical and cosmetic use10.1016/S0378-5173(99)00228-8 ↗
73. Inorganic layered double hydroxides as ascorbic acid (vitamin C) delivery system—intercalation and their controlled release properties10.1016/j.colsurfb.2009.05.005 ↗
74. Application of layered double hydroxides for removal od oxyanions: a review10.1016/j.watres.2007.10.043 ↗
75. Effects of oral l-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease10.1016/0024-3205(82)90596-3 ↗
76. In vitro sustained release of LMWH from MgAl-layered double hydroxide nanohybrids10.1021/cm703602t ↗
77. Synthesis and characterization of Cd–Cr and Zn–Cd–Cr layered double hydroxides intercalated with dodecyl sulphate10.1016/j.jssc.2005.03.020 ↗
78. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants10.1007/s10534-005-3707-9 ↗
79. Preparation of double layered hydroxides
80. Nanosize cobalt oxide-containing catalysts obtained through microwave assisted methods10.1016/j.cattod.2007.06.070 ↗
81. Stabilization of Co2+ in layered double hydroxides (LDHs) by microwave-assisted ageing10.1016/j.jssc.2006.12.011 ↗
82. Size control and optimisation of intercalated layered double hydroxides
83. Encapsulation of flavor molecules, 4-hydroxy-3-methoxy benzoic acid, into layered inorganic nanoparticles for controlled release of flavor10.1166/jnn.2008.1385 ↗
84. Crystal structure of poly(ε-caprolactone)10.1021/ma00223a017 ↗
85. Polyoxometalate complexes of layered double hydroxides
86. Controlled release of a plant growth regulator, α-naphthaleneacetate from the lamella of Zn–Al-layered double hydroxide nanocomposite10.1016/S0168-3659(02)00172-4 ↗
87. Intercalation of functional organic molecules with pharmaceutical, cosmeceutical and nutraceutical functions into layered double hydroxides and zinc basic salts
88. Utilization of layered double hydroxides in medical applications
89. Structural characterisation and delamination of lactate-intercalated Zn, Al-layered double hydroxides10.1021/cm060512y ↗
90. Influence of copper on the isomerization of eugenol for as-synthetized NiCuAl ternary hydrotalcites: an understanding through physicochemical study10.1007/s10562-009-0236-0 ↗
91. Investigation of thermal stabilization of poly(vinyl chloride) by lead stearate and its combination with synthetic hydrotalcite10.1016/j.polymdegradstab.2004.04.008 ↗
92. Preparation of layered double hydroxides
93. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma10.1016/j.rmed.2006.06.005 ↗
94. Nutritional and botanical interventions to assist with the adaptation to stress
95. Intercalation a controlled release of pharmaceutically active compounds from a layered double hydroxide10.1039/b106465g ↗
96. Intercalation chemistry of layered double hydroxides: recent development and applications10.1039/B204076J ↗
97. Recent developments in the use of layered double hydroxides as host materials for the storage and triggered release of functional10.1021/ie9012612 ↗
98. Anticancer drug-inorganic nanohybrid and its cellular interaction10.1166/jnn.2007.061 ↗
99. Preparation of glycy-l-tyrosine intercalated layered double hydroxide film and its in vitro release behavior10.1016/j.cej.2010.01.016 ↗
100. Antioxidant drugs intercalated into layered double hydroxide: structure and in vitro release10.1016/j.clay.2010.06.017 ↗